"While the FTC's lawsuit originally focused on insulin pricing practices, the settlement goes further, requiring structural changes to how Express Scripts prices drugs, manages rebates, works with pharmacies, and reports information to plan sponsors.... For employers, the agreement may signal a broader shift in the industry toward true net-cost drug pricing models, with potential implications for pharmacy benefit design, budgeting, and future PBM contracting."  MORE >>